April 18, 2007
Human Gene Technology May Show Horse Traders Where to Place Their Chips
Writer: Edith Chenault, 979-845-2886,EChenaul@ag.tamu.edu
Contact: Dr. Loren Skow, 979-845-3194,lskow@cvm.tamu.edu
COLLEGE STATION – Horse trading could come down to a computer chip,
thanks to research done at Texas A&M University's College of Veterinary
and Biomedical Sciences.
Dr. Loren Skow, professor of integrative biosciences and a member of
the faculty of genetics, and his collaborators are on the cusp of
developing whole genome high throughput genetic analysis, better known as
DNA chips, for horses. His group is particularly interested in the genetic
susceptibility of horses to certain diseases.
"When this is concluded, we will have all of the known genes of the
horse on a small silicone chip, so we can look at gene expression in
different tissues before and after exposure to a pathogen, or identify
genetic differences among individuals that help determine susceptibility
to disease," he said.
This information will be used in research; however, Skow expects in
several years, horse owners will be able to use it in making decisions
about their horses' health.
Presently, this type of technology is available for humans as well.
"We can perform a DNA chip analysis and come up with a list of genetic
markers that will identify individuals at highest risk for different
diseases, whether it be breast cancer or diabetes," he said. "Gene
profiles can be used to establish a risk factor, and a person can make
lifestyle choices to minimize those risks. We expect to do the same thing
for horses."
The development of a DNA chip that provide information about genetic
predisposition to disease came about because of earlier research done in
Skow's laboratory at Texas A&M.
"In general these are diseases that involve infectious agents, although
in some cases they are auto-immune diseases or allergies," he said. "We're
interested in the genetic variation that makes an animal more or less
susceptible to immunological disorders or infectious diseases."
Skow studies the major histocompatibility complex region—a region of
DNA present in all mammals' genomes—associated with more than 100 genetic
diseases in humans, including multiple sclerosis and diabetes.
Susceptibility to any viral, bacterial or parasitic disease, allergies
or auto-immune disorders may be influenced by the genes in the major
histocompatibility complex, he said.
The early work on the horse genome at Texas A&M was supported in part
by the Texas Equine Research Account. The account is funded by the
education code of the Texas Racing Act in 1995. An 11-member committee
advises and assists the director of the Texas Agricultural Experiment
Station in administering the account, said Dr. Mark Hussey, associate
director for programs.
"Twelve years later we have the whole genome sequence of the horse (
http://www.broad.mit.edu./mammals/horse ), which is pretty amazing," Skow
said. "When we had our first meeting in Kentucky, we were just trying to
get organized and map a few genes on a few chromosomes," he said. "The
Texas Equine Research Fund was critical getting the effort at Texas A&M
started and provided critical preliminary information that has resulted in
more than $3 million in extramural research funds for genomic research in
horses."
Members of the committee are from Texas A&M, Tarleton State University,
Texas Tech University, research organizations with equine research
capabilities, and the major horse breed associations in the state.
-30-
|